Key facts
- This page summarizes Dolev Rafaeli's Form 4 filing for STRATA Skin Sciences, Inc. (SSKN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2025, 17:09.
Dolev Rafaeli - 13 May 2025 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- SSKN
- Reported as of
- 13 May 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2025, 17:09:40 UTC
- Prior SEC filing
- 17 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dolev Rafaeli
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dolev Rafaeli filed Form 4 for STRATA Skin Sciences, Inc. (SSKN) on 15 May 2025.
Change
- Previous filing in this sequence was filed on 17 Jul 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001536967
Primary reporting owner
Rafaeli Dolev
- Relationship
- Chief Executive Officer, Director
- Address
- C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, STE. 140, HORSHAM
- Signature
- /s/ Dolev Rafaeli
- Signature date
- 15 May 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SSKN
transaction
Derivative
SSKN Stock Options
Award
- Transaction value
- $0
- Shares
- +58,000
- Change %
- +33%
- Price
- $0.000000
- Shares after
- 232,557
- Date
- 13 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,000
- Exercise price
- $2.55
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Options to Purchase 14,500 option shares shall vest on each of May 13, 2026, May 13, 2027, May 13, 2028 and May 13, 2029.
Footnote F2
Ownership figures prior to the date hereof have been adjusted to reflect the 10 for 1 reverse stock split effected by the Company on June 6, 2024.